• Something wrong with this record ?

Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization

R. Voldřich, D. Netuka, F. Charvát, V. Beneš

. 2022 ; 136 (1) : 175-184. [pub] 20210625

Language English Country United States

Document type Journal Article

OBJECTIVE: The natural course of dural arteriovenous fistulas (DAVFs) is unfavorable. Transarterial embolization with Onyx is currently the therapeutic method of choice, although the long-term stability of Onyx has been questioned. The literature reports a significant difference in the recurrence rate after complete DAVF occlusion and lacks larger series with long-term follow-up. The authors present the largest series to date with a long-term follow-up to determine the stability of Onyx, prospectively comparing magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) as follow-up diagnostic methods. METHODS: Demographics, clinical symptomatology, length of follow-up, diagnostic methods, and angiographic findings of DAVFs were recorded and retrospectively evaluated in 112 patients. A prospective group of 15 patients with more than 5 years of follow-up after complete DAVF occlusion was established. All 15 patients in the prospective group underwent a clinical examination and MRA; 10 of these patients also underwent DSA. The recurrences and the correlation between the two diagnostic methods were evaluated. RESULTS: Among the 112 patients, 71 were men and 41 were women, with an average age of 60 years. Intracranial hemorrhage (40%) was the most common clinical presentation of DAVF. At the last follow-up, 73% of the patients experienced clinical improvement, 21% remained unchanged, and 6% worsened. Overall, 87.5% of the DAVFs were occluded entirely with endovascular treatment, and 93% of the DAVFs were classified as cured at the last follow-up (i.e., completely embolized DAVFs and DAVFs that thrombosed spontaneously or after Gamma Knife surgery). Two recurrences of DAVFs were recorded in the entire series. Both were first diagnosed by MRA and confirmed with DSA. The mean follow-up was 27.7 months. In the prospective group, a small asymptomatic recurrence was diagnosed. The mean follow-up of the prospective group was 96 months. CONCLUSIONS: Onyx is a stable embolic material, although recurrence of seemingly completely occluded DAVFs may develop because of postembolization hemodynamic changes that accentuate primarily graphically absent residual fistula. These residuals can be diagnosed with MRA at follow-up. The authors' data suggest that MRA could be sufficient as the follow-up diagnostic method after complete DAVF occlusion with Onyx. However, larger prospective studies on this topic are needed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012391
003      
CZ-PrNML
005      
20220506130041.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.3171/2020.12.JNS203811 $2 doi
035    __
$a (PubMed)34171837
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Voldřich, Richard $u 1Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Central Military Hospital; and
245    10
$a Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization / $c R. Voldřich, D. Netuka, F. Charvát, V. Beneš
520    9_
$a OBJECTIVE: The natural course of dural arteriovenous fistulas (DAVFs) is unfavorable. Transarterial embolization with Onyx is currently the therapeutic method of choice, although the long-term stability of Onyx has been questioned. The literature reports a significant difference in the recurrence rate after complete DAVF occlusion and lacks larger series with long-term follow-up. The authors present the largest series to date with a long-term follow-up to determine the stability of Onyx, prospectively comparing magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) as follow-up diagnostic methods. METHODS: Demographics, clinical symptomatology, length of follow-up, diagnostic methods, and angiographic findings of DAVFs were recorded and retrospectively evaluated in 112 patients. A prospective group of 15 patients with more than 5 years of follow-up after complete DAVF occlusion was established. All 15 patients in the prospective group underwent a clinical examination and MRA; 10 of these patients also underwent DSA. The recurrences and the correlation between the two diagnostic methods were evaluated. RESULTS: Among the 112 patients, 71 were men and 41 were women, with an average age of 60 years. Intracranial hemorrhage (40%) was the most common clinical presentation of DAVF. At the last follow-up, 73% of the patients experienced clinical improvement, 21% remained unchanged, and 6% worsened. Overall, 87.5% of the DAVFs were occluded entirely with endovascular treatment, and 93% of the DAVFs were classified as cured at the last follow-up (i.e., completely embolized DAVFs and DAVFs that thrombosed spontaneously or after Gamma Knife surgery). Two recurrences of DAVFs were recorded in the entire series. Both were first diagnosed by MRA and confirmed with DSA. The mean follow-up was 27.7 months. In the prospective group, a small asymptomatic recurrence was diagnosed. The mean follow-up of the prospective group was 96 months. CONCLUSIONS: Onyx is a stable embolic material, although recurrence of seemingly completely occluded DAVFs may develop because of postembolization hemodynamic changes that accentuate primarily graphically absent residual fistula. These residuals can be diagnosed with MRA at follow-up. The authors' data suggest that MRA could be sufficient as the follow-up diagnostic method after complete DAVF occlusion with Onyx. However, larger prospective studies on this topic are needed.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a digitální subtrakční angiografie $7 D015901
650    _2
$a cévní malformace centrálního nervového systému $x diagnostické zobrazování $x terapie $7 D020785
650    _2
$a mozková angiografie $x metody $7 D002533
650    12
$a dimethylsulfoxid $7 D004121
650    _2
$a terapeutická embolizace $x metody $7 D004621
650    _2
$a endovaskulární výkony $7 D057510
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční angiografie $7 D018810
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a polyvinyly $7 D011145
650    _2
$a prospektivní studie $7 D011446
650    _2
$a recidiva $7 D012008
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Netuka, David $u 1Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Central Military Hospital; and
700    1_
$a Charvát, František $u 2Department of Neuroradiology, Central Military Hospital, Prague, Czech Republic
700    1_
$a Beneš, Vladimír $u 1Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Central Military Hospital; and
773    0_
$w MED00002843 $t Journal of neurosurgery $x 1933-0693 $g Roč. 136, č. 1 (2022), s. 175-184
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34171837 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130034 $b ABA008
999    __
$a ok $b bmc $g 1789825 $s 1163592
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 136 $c 1 $d 175-184 $e 20210625 $i 1933-0693 $m Journal of neurosurgery $n J Neurosurg $x MED00002843
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...